Drug candidate
Frequency Percent of responses Percent of cases
Chloroquine/hydroxychloroquine
31 13.6 25
Lopinavir
34 14.91 27.42
Ritonavir
38 16.67 30.65
Interferon alpha
22 9.65 17.74
Favipravir
9
3.95 7.26
ASCO9
1
0.44 0.81
Oseltamivir
2
0.88 1.61
Remdesvir
10 4.39 8.06
Umifenovir
9
3.95 7.26
Triazavirin
1
0.44 0.81
Baloxavir marboxil
2
0.88 1.61
Danoprevir
3 1.32 2.42
Azvudine
4
1.75 3.23
Sofosbuvir
2
0.88 1.61
Ledispasvir
1
0.44 0.81
Daclatasvir
1 0.44 0.81
Darunavir
6 2.63 4.84
Cobicistat
3
1.32 2.42
Emtricitabine
1 0.44 0.81
Tenofovir
1
0.44 0.81
Pirfenidone
3
1.32 2.42
Carimycin
2
0.88 1.61
Methylprednisolone
5 2.19 4.03
Tocilizumab
6
2.63 4.84
Adalimumab
2
0.88 1.61
Eculizumab
1
0.44 0.81
Sarilumab
1
0.44 0.81
Ixekizumab
1
0.44 0.81
Ribavirin
3
1.32 2.42
Bromhexine
1
0.44 0.81
Tranilast
1
0.44 0.81
Thymosin
3
1.32 2.42
Ebastine
1
0.44 0.81
Dexamethasone
1 0.44 0.81
Fingolimod
1 0.44 0.81